Aquestive Therapeutics

40.633229
Warren, NJ 07059

Aquestive Therapeutics News

AQUESTIVE THERAPEUTICS: Granted Temporary Restraining Order (TRO) Against Alvogen

Aquestive Therapeutics, Inc. (Nasdaq: AQST), a specialty pharmaceutical company, focused on developing and commercializing differentiated products to solve therapeutic problems, announced that the U.S. District Court for the District of New Jersey has granted a temporary restraining order (TRO) that enjoins Alvogen from initiating any launch activities related to its generic buprenorphine/naloxone sublingual film. Read More »